y 27632 has been researched along with arginyl-glycyl-aspartic acid in 1 studies
Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (arginyl-glycyl-aspartic acid) | Trials (arginyl-glycyl-aspartic acid) | Recent Studies (post-2010) (arginyl-glycyl-aspartic acid) |
---|---|---|---|---|---|
1,924 | 3 | 891 | 4,556 | 17 | 1,799 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, J; Lin, F; Pang, M; Teng, Y; Xiong, C; Yuan, Y | 1 |
1 other study(ies) available for y 27632 and arginyl-glycyl-aspartic acid
Article | Year |
---|---|
Substrate stiffness promotes latent TGF-β1 activation in hepatocellular carcinoma.
Topics: Amides; Carcinoma, Hepatocellular; Cell Line, Tumor; Cytoskeleton; Extracellular Matrix; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Integrin beta1; Liver Neoplasms; Oligopeptides; Protein Binding; Pyridines; rho GTP-Binding Proteins; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta1; Up-Regulation | 2017 |